Title 18. Disease Prevention — Subtitle 9A. Covid–19 Testing, Contact Tracing, and Vaccination Act
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health-Gen. § 18-9A-01 (2026)
Title 18. Disease Prevention
Subtitle 9A. Covid–19 Testing, Contact Tracing, and Vaccination Act
§ 18–9A-01LinkCopy Citation
(a)
In this section the following words have the meanings indicated.
(b)
“COVID–19” means, interchangeably and collectively, the coronavirus known as COVID–19 or 2019–nCoV and the SARS–CoV–2 virus.
(c)
“COVID–19 test” means an in vitro diagnostic test for the detection of SARS–CoV–2 or the diagnosis of the virus that causes COVID–19, as described in § 3201 of the federal Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Md. Code Ann., Health-Gen. § 18-9A-02 (2026)
Title 18. Disease Prevention
Subtitle 9A. Covid–19 Testing, Contact Tracing, and Vaccination Act
§ 18–9A-02LinkCopy Citation
(a)
On or before June 1, 2021, the Department, in collaboration with local health departments in the State and the Maryland State Department of Education, shall adopt and implement a 2–year plan to respond to the outbreak of COVID–19.
(b)
The plan required under this section shall:
(1)
Include measures to enhance public health efforts at the State and local level to monitor, prevent, and mitigate the spread of COVID–19;
(2)
(i)
Assess the COVID–19 public and private testing infrastructure in place both statewide and in each local jurisdiction;
(ii)
Identify and address the unmet needs for COVID–19 testing statewide and in each local jurisdiction, including the number and location of public and private testing providers required to ensure access to testing on demand for all residents of the State;
(iii)
Establish specific monthly goals for COVID–19 testing statewide and in each local jurisdiction to ensure access to testing for all residents of the State, including:
(1)
A goal to achieve the capacity to perform the surveillance testing required to safely reopen and keep open schools, institutions of higher education, workplaces, and other community facilities in the State while minimizing the community spread of COVID–19 in calendar years 2021 and 2022 through a network of public and private testing providers; and
(2)
For each local jurisdiction, a goal to establish the required number of public or private COVID–19 testing locations to achieve the surveillance testing goal described in item 1 of this item; and
(iv)
Estimate the funding required to implement the surveillance testing goal described in item (iii)1 of this item and the extent to which federal funding already received by the State in fiscal year 2021 and federal funding that is provided to the State and received after March 1, 2021, can be used to cover the cost required to achieve that goal;
(3)
(i)
Assess the contact tracing infrastructure in place for COVID–19 both statewide and in each local jurisdiction;
(ii)
Determine the optimal number of contact tracing, case management, care resource coordination, and other personnel per 100,000 residents needed in each jurisdiction to effectively monitor, prevent, and mitigate the spread of COVID–19;
(iii)
Identify and address the unmet needs for COVID–19 contact tracing and related outbreak prevention and mitigation efforts both statewide and in each local jurisdiction; and
(iv)
(1)
Establish goals for identifying, locating, and testing individuals who have been in close contact with individuals who test positive for COVID–19 that are in alignment with Centers for Disease Control and Prevention guidance for effective contact tracing programs; and
(2)
Include a mechanism for monitoring performance of contact tracing and testing of contacts both statewide and for each local jurisdiction;
(4)
Require the Department to assist local jurisdictions that adopt strategies to:
(i)
Accelerate access to and the use of at–home collection and point–of–care tests for COVID–19; and
(ii)
Incentivize and encourage pharmacies and health care providers, including primary care providers, to provide COVID–19 testing; and
(5)
Allow each local jurisdiction to establish and implement a program for COVID–19 contact tracing that is independent from the contact tracing program performed by the State or the entity with whom the State has contracted to perform contact tracing for the State.
(c)
The plan required under this section shall have a design that addresses the disproportionate impact of the COVID–19 pandemic on underserved and minority communities in the State.
(d)
On or before June 1, 2021, the Department shall submit the plan required under this section to the General Assembly, in accordance with § 2–1257 of the State Government Article.
(e)
(1)
(i)
For fiscal years 2021 and 2022, the Department shall provide $25,000,000 each year in grants to local jurisdictions to expand capacity for COVID–19 testing and contact tracing, or for any other public health purpose related to COVID–19 response for which federal funding is authorized.
(ii)
Grant funding provided for COVID–19 response under subparagraph (i) of this paragraph shall be divided between local jurisdictions in proportion to their respective populations.
(iii)
The Department shall provide additional grant funding to a local jurisdiction to supplement the grant funding allocated to the local jurisdiction under subparagraphs (i) and (ii) of this paragraph if the Department determines that the initial allocation of grant funding is not sufficient to meet the COVID–19 testing and contact tracing needs of the local jurisdiction.
(iv)
A local jurisdiction may use grant funding provided under this subsection to expand COVID–19 testing capacity through direct testing efforts by the health department of the local jurisdiction or by contracting with other entities to provide testing.
(2)
(i)
For fiscal years 2021 and 2022 and in addition to any funding provided under paragraph (1) of this subsection, the Department shall provide funding to local jurisdictions that elect to establish and implement a program for COVID–19 contact tracing that is independent from the contact tracing program performed by the State or the entity with whom the State has contracted to perform contact tracing for the State.
(ii)
The amount of funding provided to a local jurisdiction for COVID–19 contact tracing under subparagraph (i) of this paragraph shall be equivalent to the cost per case amount provided to the entity with whom the State has contracted to perform contact tracing for the State.
(3)
(i)
For fiscal years 2021 and 2022, the Department shall provide $15,000,000 each year in grants to local jurisdictions to vaccinate residents of the local jurisdiction against COVID–19.
(ii)
Grant funding provided for COVID–19 vaccination under this subsection shall be divided between local jurisdictions in proportion to their respective populations.
(iii)
The Department shall provide additional grant funding to a local jurisdiction to supplement the grant funding allocated to the local jurisdiction under subparagraphs (i) and (ii) of this paragraph if the Department determines that the initial allocation of grant funding is not sufficient to meet the COVID–19 vaccination needs of the local jurisdiction.
(4)
The Department may use only federal funding allocated to the State under the Coronavirus Response and Relief Supplemental Appropriations Act and any other federal legislation enacted in calendar years 2020 through 2022 to provide funding required under this section.
(f)
(1)
To the extent practicable, the Department shall provide up to $9,000,000 in fiscal year 2021 and $36,000,000 in fiscal year 2022 in grant funding to assisted living programs and home health agencies in calendar year 2021 to cover the cost of COVID–19 testing for residents, patients, and staff.
(2)
The Department may use only federal funding allocated to the State under the Coronavirus Response and Relief Supplemental Appropriations Act and any other federal legislation enacted in calendar years 2020 through 2022 to provide funding required under this subsection.
Md. Code Ann., Health-Gen. § 18-9A-03 (2026)
Title 18. Disease Prevention
Subtitle 9A. Covid–19 Testing, Contact Tracing, and Vaccination Act
§ 18–9A-03LinkCopy Citation
(a)
(1)
On or before June 1, 2021, the Department, with input from subject matter experts and other relevant stakeholders, shall develop and submit to the General Assembly a comprehensive plan for vaccinating residents of the State against COVID–19.
(2)
The plan required under paragraph (1) of this subsection shall include:
(i)
Detailed information on:
(1)
The categories of residents of the State who will receive priority access to vaccines for COVID–19;
(2)
The timeline for providing vaccines for COVID–19 to residents in each of the priority categories and to members of the general public who are not included in priority categories; and
(3)
Target metrics for vaccinating residents in each of the priority categories and for members of the general public who are not included in priority categories;
(ii)
A dedication of time and resources to target vaccine distribution and vaccine safety outreach efforts to communities that have been disproportionately impacted by COVID–19 infection, morbidity, and mortality;
(iii)
A vaccine distribution strategy that allocates resources and vaccines across all partners and vaccination sites in an equitable manner that ensures that the vaccine allocation by jurisdiction accounts for the disproportionate impact of the COVID–19 pandemic on underserved and minority communities; and
(iv)
A strategy for outreach and distribution of vaccines to individuals who are not receiving the vaccine, due to either lack of access or vaccine hesitancy.
(b)
After submitting the COVID–19 vaccine plan to the General Assembly as required under subsection (a) of this section, the Department shall provide weekly progress reports on implementation of the COVID–19 vaccine plan to the General Assembly for the duration of calendar year 2021.
(c)
The COVID–19 vaccine plan and progress reports required under this section shall be submitted to the General Assembly in accordance with § 2–1257 of the State Government Article.
Md. Code Ann., Health-Gen. § 18-9A-04 (2026)
Title 18. Disease Prevention
Subtitle 9A. Covid–19 Testing, Contact Tracing, and Vaccination Act
§ 18–9A-04LinkCopy Citation
(a)
The Department shall convene a Maryland Public Health Modernization Workgroup.
(b)
The Workgroup shall include representatives of the Department, local health departments, subject matter experts, and any other relevant stakeholders.
(c)
The Workgroup shall:
(1)
Assess the current public health infrastructure and resources in the State;
(2)
Make recommendations for how to establish a modern and effective public health system with a capacity to:
(i)
Monitor, prevent, control, and mitigate the spread of infectious disease; and
(ii)
Achieve State Health Improvement Process goals;
(3)
Make recommendations regarding the establishment of a Maryland Public Health Job Corps to respond to the outbreak of COVID–19 or similar outbreaks; and
(4)
Consider, where appropriate, the use of federal funds to implement any recommendations made under this subsection.
(d)
On or before December 1, 2021, the Department shall submit a report to the General Assembly, in accordance with § 2–1257 of the State Government Article, that includes the findings and recommendations of the Workgroup established under this section.